Insmed | INSM - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Cytokinetics USD 30.33M 4.01M 2025-12
DBV Technologies USD 461K 323.71K 2025-03
Gilead Sciences USD 255M 1000K 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 20.6M 217K 2025-12
Novartis USD 281M 8M 2025-09
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Ultragenyx Pharmaceutical USD 19M 4.85M 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12